Prescription Drug Affordability Board meeting 07/15/2026
Prescription Drug Affordability Board · July 15, 2026
The Prescription Drug Affordability Board met to review its 2026 eligible drug list and draft affordability reports for Enbrel and Xtandi, discussed upper-payment-limit (UPL) rulemaking and inter-state legal developments, and scheduled an executive session to review confidential price data.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.